Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 20, 2017 Filed Sep 22, 2017 16:01 UTC |
Leire, Eric Jean MarieChief Executive Officer
|
GrantCommon Stock | 62,687 | $1.80 | $112,836.60 |
DisclosureSEC source: 0001213900-17-009917 · f4092017leire_dandritbiotech.xml · nonDerivative · entry 1 Leire, Eric Jean Marie · CIK 0001600390 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,302 Read SEC document |
| September 20, 2016 Filed Sep 29, 2016 13:03 UTC |
Leire, Eric Jean MarieDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001213900-16-017130 · f4092016leire_dandrit.xml · derivative · entry 1 Leire, Eric Jean Marie · CIK 0001600390 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2019-12-31 Read SEC document |
| September 20, 2016 Filed Sep 29, 2016 13:04 UTC |
Nielsen, Niels ErikDirector
|
GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001213900-16-017133 · f4092016nielsen_dandrit.xml · derivative · entry 1 Nielsen, Niels Erik · CIK 0001600391 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2019-12-31 Read SEC document |
| September 20, 2016 Filed Sep 29, 2016 17:05 UTC |
PETERSEN ALDODirector
|
GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001213900-16-017136 · f4092016petersen_dandrit.xml · derivative · entry 1 PETERSEN ALDO · CIK 0001528329 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2019-12-31 F1 · ownership.nature: The stock options were issued to APE Invest A/S, a Danish company controlled by Mr. Petersen. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.